A Case of Successful Danazol Therapy in Autoimmune Thrombocytopenia Associated with Systemic Lupus Erythematosus
Journal of the Korean Pediatric Society
;
: 1330-1333, 2001.
Artículo
en Coreano
| WPRIM
| ID: wpr-70074
ABSTRACT
Autoimmune thrombocytopenia and autoimmune hemolytic anemia occur in 10-26% of patients with systemic lupus erythematosus(SLE). These hematological manifestations may be the sole presenting sign and can precede the appearance of diagnosable SLE in 5 to 23% of cases. The conventional treatment for SLE associated with these disorders includes corticosteroid therapy and splenectomy, but autoimmune thrombocytopenia or autoimmune hemolytic anemia may be refractory to both treatments. We experienced a case of a SLE patient complicated by severe autoimmune thrombocytopenia. Therapy with intravenous immunoglobulin and corticosteroids failed. She responded to danazol and remission of thrombocytopenia(platelet >100,000/mm3) was observed 7 days after starting danazol. Danazol therapy seems to be a useful and well tolerated treatment for refractory autoimmune thrombocytopenia associated with SLE.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Esplenectomía
/
Inmunoglobulinas
/
Púrpura Trombocitopénica Idiopática
/
Corticoesteroides
/
Danazol
/
Anemia Hemolítica Autoinmune
/
Lupus Eritematoso Sistémico
Límite:
Humanos
Idioma:
Coreano
Revista:
Journal of the Korean Pediatric Society
Año:
2001
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS